Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01626170 · ClinicalTrials.gov registry record
Studying Mechanisms of Radiation Therapy Resistance in Samples From Younger Patients With Rhabdomyosarcoma
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 20
- Enrollment target
NCT01626170 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 20 participants.
The verdict
NCT01626170 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This laboratory study is looking into mechanisms of radiation therapy resistance in samples from younger patients with rhabdomyosarcoma. Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors find better ways to treat cancer
Interventions
- OTHER laboratory biomarker analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01626170
The ClinicalTrials.gov registry entry for NCT01626170 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which laboratory biomarker analysis is the first listed.
NCT01626170 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01626170 about?
NCT01626170 is a clinical study titled "Studying Mechanisms of Radiation Therapy Resistance in Samples From Younger Patients With Rhabdomyosarcoma". This laboratory study is looking into mechanisms of radiation therapy resistance in samples from younger patients with rhabdomyosarcoma. Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related ...
What is the current status of trial NCT01626170?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2012-06.
What interventions are being tested in trial NCT01626170?
The interventions under investigation include: laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT01626170?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.